Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Format
Liquid
Buffer
50 % glycerol
Handling Advice
Aliquot to avoid repeated freezing and thawing.
Storage
-20 °C
Storage Comment
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Jin, Yu, Dong, Zhou, Gu, Yu, Yu, Lu, Xian, Liu, Cong, Wu: "SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma." in: Journal of hepatology, Vol. 59, Issue 3, pp. 510-7, (2013) (PubMed).
Ebert, Kisiela, Wsól, Maser: "Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29." in: Chemico-biological interactions, Vol. 191, Issue 1-3, pp. 239-49, (2011) (PubMed).
Loeffler-Ragg, Mueller, Gamerith, Auer, Skvortsov, Sarg, Skvortsova, Schmitz, Martin, Krugmann, Alakus, Maser, Menzel, Hilbe, Lindner, Schmid, Zwierzina: "Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomib." in: Molecular cancer therapeutics, Vol. 8, Issue 7, pp. 1995-2006, (2009) (PubMed).
Target
AKR1B10
(Aldo-Keto Reductase Family 1, Member B10 (Aldose Reductase) (AKR1B10))